Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
N-myc downstream regulated gene 4 (NDRG4) is a new member of the NDRG family of genes discovered in recent years, and its expression is regulated by various factors. Studies have shown that the NDRG4 gene is closely related to the development of heart and brain and the maintenance of certain malignant tumors. As a candidate tumor suppressor gene, NDRG4 is expected to contribute to the study of tumor prevention and treatment.
The Basic Structure and Characteristics of the NDRG4 Gene
The NDRG4 gene and the other three genes NDRG1, NDEG2, and NDRG3 together form the NDRG gene family. The amino acid sequence of the encoded protein is 57%-65% homologous. The NDRG1 gene and the NDRG3 gene are highly homologous, while the NDRG2 gene and the NDRG4 gene belongs to another homologous subtype. Unlike ubiquitous expression of NDRG1 protein, NDRG2 protein is highly expressed in adult skeletal muscle and brain tissue, and NDRG3 protein is mainly expressed in brain and testis. The NDRG4 protein is highly expressed in the heart and brain tissue and is involved in cell differentiation and synapse formation. NDRG4-B protein is expressed only in brain tissue, while NDRG4-H protein is expressed in both brain and heart tissues, and NDRG4-Bvar protein is expressed as a minor product. Moreover, the expression level of NDRG4 protein is more abundant in the adult heart and brain tissue, but is significantly lower in the brain tissue of patients with Alzheimer's disease. The mRNA transcription levels of the three NDRG4 subtypes are regulated by alternative splicing and may also be involved in promoter selection.
Figure 1. Proposed pathway model for NDRG4 involved in myoblast differentiation. (Zhu, M., et al. 2017)
Expression Regulation of NDRG4 Gene
Tbx2 is a member of the transcription factor T-box family of genes and plays an important role in the development of embryonic cardiac heart. The Tbx2 gene may cross-regulate transcription with other T-box family genes, and together inhibit the production of the NDRG family of NDRG2, NDRG4 proteins and corresponding adhesion factors, thereby regulating cardiac development. In addition, studies have shown that reducing the activity of the Tbx5 gene in the heart can down-regulate the expression of the NDRG4 gene. Conversely, the high expression of the Tbx5 gene due to Tbx20 gene knockdown can up-regulate NDRG4 gene expression, suggesting that the NDRG4 gene may be a downstream regulatory target of Tbx5.
NDRG4 and Tumor
The cellular and biochemical functions of the NDRG4 gene in astrocytes and glioblastoma multiforme (GBM) cells were studied. The results showed that the expression of the NDRG4 gene was up-regulated in GBM and was required for the survival of astrocytes and GBM cell lines in vitro as well as GBM xenograft cells. Overexpression of NDRG4 does not affect cell survival. Conversely, NDRG4 knockout causes cell arrest in G1 phase leading to apoptosis. The initial G1 arrest is associated with decreased expression of the cell cycle protein D1 and increased expression of the p27Kip1 gene, and subsequent apoptosis is associated with decreased expression of the sex-linked inhibitor of apoptosis protein (XlAP) and survivin. In addition, NDRG4 gene knockdown also reduced the tumorigenic capacity of GBM cell lines after implantation into the head of a nude mouse. In conclusion, these results indicate that the NDRG4 gene plays an important role in maintaining GBM cell cycle and cell survival. Therefore, it is different from the tumor suppressor effect of the homologous gene NDRG2 in astrocytes and GBM cells, suggesting that the tumor suppressor effect of NDRG4 gene also has tumor cell source specificity.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.